*ST大药(603963.SH)：拟变更募集资金投资项目

格隆汇资讯06-26

格隆汇6月26日丨*ST大药(603963.SH)公布，公司拟将原投向由本公司实施的“中药注射剂二次开发研究项目”、“药品研发技术中心建设项目”子项目“研发中心建设项目”、“营销网络建设项目”（合称“原项目”）的募集资金，变更为投向由本公司全资子公司销售公司实施的“大理药业医药配送项目”。本次涉及变更投向的募集资金金额为12,888.04万元，占公司实际募集资金总额的49.10%。同时，为了提高...

网页链接

免责声明：本文观点仅代表作者个人观点，不构成本平台的投资建议，本平台不对文章信息准确性、完整性和及时性做出任何保证，亦不对因使用或信赖文章信息引发的任何损失承担责任。

精彩评论

我们需要你的真知灼见来填补这片空白

发表看法

{"i18n":{"language":"zh_CN"},"isChannel":false,"data":{"share":"https://www.laohu8.com/m/news/2446036620?lang=zh_CN&edition=full","thumbnail":"","is_english":false,"pubTime":"2024-06-26 19:05","share_image_url":"https://static.laohu8.com/9a95c1376e76363c1401fee7d3717173","id":"2446036620","market":"sh","top_or_hot":-1,"title":"*ST大药(603963.SH)：拟变更募集资金投资项目","media":"格隆汇资讯","content":"<div>\n<p>格隆汇6月26日丨*ST大药(603963.SH)公布，公司拟将原投向由本公司实施的“中药注射剂二次开发研究项目”、“药品研发技术中心建设项目”子项目“研发中心建设项目”、“营销网络建设项目”（合称“原项目”）的募集资金，变更为投向由本公司全资子公司销售公司实施的“大理药业医药配送项目”。本次涉及变更投向的募集资金金额为12,888.04万元，占公司实际募集资金总额的49.10%。同时，为了提高...</p>\n\n<a href=\"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024062619052995da0d1d&s=b\">网页链接</a>\n\n</div>\n","source":"tencent","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>*ST大药(603963.SH)：拟变更募集资金投资项目</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n*ST大药(603963.SH)：拟变更募集资金投资项目\n</h2>\n\n<h4 class=\"meta\">\n\n\n2024-06-26 19:05 北京时间&nbsp;&nbsp;&nbsp;<a href=http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024062619052995da0d1d&s=b><strong>格隆汇资讯</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>格隆汇6月26日丨*ST大药(603963.SH)公布，公司拟将原投向由本公司实施的“中药注射剂二次开发研究项目”、“药品研发技术中心建设项目”子项目“研发中心建设项目”、“营销网络建设项目”（合称“原项目”）的募集资金，变更为投向由本公司全资子公司销售公司实施的“大理药业医药配送项目”。本次涉及变更投向的募集资金金额为12,888.04万元，占公司实际募集资金总额的49.10%。同时，为了提高...</p>\n\n<a href=\"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024062619052995da0d1d&s=b\">网页链接</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK0239","symbol_name":"医药制造","start_time":0,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024062619052995da0d1d&s=b","article_id":"2446036620","we_media_id":null,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024062619052995da0d1d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"url":"https://stock-news.laohu8.com/highlight/detail?id=2446036620","pubTimestamp":1719399919,"sourceInfo":{"source_id":"tencent","name":"腾讯"},"weMediaInfo":null,"summary":"格隆汇6月26日丨*ST大药公布，公司拟将原投向由本公司实施的“中药注射剂二次开发研究项目”、“药品研发技术中心建设项目”子项目“研发中心建设项目”、“营销网络建设项目”的募集资金，变更为投向由本公司全资子公司销售公司实施的“大理药业医药配送项目”。本次涉及变更投向的募集资金金额为12,888.04万元，占公司实际募集资金总额的49.10%。","collect":0,"end_time":0,"defaultTopTitle":"qq.com","property":[],"viewcount":null,"language":"zh","relate_stocks":{"603963":"*ST大药","BK0239":"医药制造"},"translate_title":"* ST Dayao (603963. SH): plans to change the investment project of raised funds","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"603963":1},"content_text":"格隆汇6月26日丨*ST大药(603963.SH)公布，公司拟将原投向由本公司实施的“中药注射剂二次开发研究项目”、“药品研发技术中心建设项目”子项目“研发中心建设项目”、“营销网络建设项目”（合称“原项目”）的募集资金，变更为投向由本公司全资子公司销售公司实施的“大理药业医药配送项目”。本次涉及变更投向的募集资金金额为12,888.04万元，占公司实际募集资金总额的49.10%。同时，为了提高资金使用效率，降低公司财务成本，公司拟将闲置募集资金购买理财产品的实际收益1,138.36万元（未包含未到期理财产品收益，具体金额以到期赎回该笔理财取得的收益为准），募集资金专户产生的利息12.07万元（已扣减手续费，具体金额以实际结转时专户产生的利息为准），合计1,150.43万元（具体金额以实际结转时项目专户资金余额为准）用于永久补充流动资金，计划用于偿还公司到期有息负债及储备必要的流动资金防范流动性风险。","kind":null,"is_publish_news":true,"is_publish_highlight":false,"is_publish_live":null,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"","news_tag":"","news_rank":0,"symbols":[],"gpt_button":1},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.24.2","shortVersion":"4.24.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2446036620"}